Exec Chat: Medtronic’s Goodheart Talks About COVID, AI, Diversity, TAVR And More

Medtech Insight sat down with Nina Goodheart, the president of Medtronic’s structural heart and aortic operating unit, to learn more about her experience with the company during the pandemic, the company’s commitment to diversity and inclusion, and the future of structural heart technology.

Heart Valve
• Source: Shutterstock (Shutterstock)

As the market for transcatheter valve devices continues to grow, structural heart devices have become one of Medtronic’s strengths.

Sales of its transcatheter valves grew 11% globally in the first quarter of fiscal 2024 (calendar May to July 2023), led by rapid adoption of Evolut FX, the fourth generation...

More from Cardiology

More from Device Area